460 related articles for article (PubMed ID: 30953527)
1. Glial phagocytic clearance in Parkinson's disease.
Tremblay ME; Cookson MR; Civiero L
Mol Neurodegener; 2019 Apr; 14(1):16. PubMed ID: 30953527
[TBL] [Abstract][Full Text] [Related]
2. Phagocytic clearance of presynaptic dystrophies by reactive astrocytes in Alzheimer's disease.
Gomez-Arboledas A; Davila JC; Sanchez-Mejias E; Navarro V; Nuñez-Diaz C; Sanchez-Varo R; Sanchez-Mico MV; Trujillo-Estrada L; Fernandez-Valenzuela JJ; Vizuete M; Comella JX; Galea E; Vitorica J; Gutierrez A
Glia; 2018 Mar; 66(3):637-653. PubMed ID: 29178139
[TBL] [Abstract][Full Text] [Related]
3. Phagocytic clearance in neurodegeneration.
Sokolowski JD; Mandell JW
Am J Pathol; 2011 Apr; 178(4):1416-28. PubMed ID: 21435432
[TBL] [Abstract][Full Text] [Related]
4. α-Synuclein and Glia in Parkinson's Disease: A Beneficial or a Detrimental Duet for the Endo-Lysosomal System?
Filippini A; Gennarelli M; Russo I
Cell Mol Neurobiol; 2019 Mar; 39(2):161-168. PubMed ID: 30637614
[TBL] [Abstract][Full Text] [Related]
5. Role of α-synuclein in microglia: autophagy and phagocytosis balance neuroinflammation in Parkinson's disease.
Lv QK; Tao KX; Wang XB; Yao XY; Pang MZ; Liu JY; Wang F; Liu CF
Inflamm Res; 2023 Mar; 72(3):443-462. PubMed ID: 36598534
[TBL] [Abstract][Full Text] [Related]
6. Microglia and astrocyte dysfunction in parkinson's disease.
Kam TI; Hinkle JT; Dawson TM; Dawson VL
Neurobiol Dis; 2020 Oct; 144():105028. PubMed ID: 32736085
[TBL] [Abstract][Full Text] [Related]
7. [Abeta, tau and alpha-synuclein and glial cells].
Akiyama H
Nihon Shinkei Seishin Yakurigaku Zasshi; 2006 Feb; 26(1):23-31. PubMed ID: 16637593
[TBL] [Abstract][Full Text] [Related]
8. Astrocytes and retrograde degeneration of nigrostriatal dopaminergic neurons in Parkinson's disease: removing axonal debris.
Morales I; Puertas-Avendaño R; Sanchez A; Perez-Barreto A; Rodriguez-Sabate C; Rodriguez M
Transl Neurodegener; 2021 Nov; 10(1):43. PubMed ID: 34727977
[TBL] [Abstract][Full Text] [Related]
9. Generation of a Novel Mouse Model of Parkinson's Disease via Targeted Knockdown of Glutamate Transporter GLT-1 in the Substantia Nigra.
Zhang Y; Meng X; Jiao Z; Liu Y; Zhang X; Qu S
ACS Chem Neurosci; 2020 Feb; 11(3):406-417. PubMed ID: 31909584
[TBL] [Abstract][Full Text] [Related]
10. Microglial Phagocytosis and Its Regulation: A Therapeutic Target in Parkinson's Disease?
Janda E; Boi L; Carta AR
Front Mol Neurosci; 2018; 11():144. PubMed ID: 29755317
[TBL] [Abstract][Full Text] [Related]
11. Modification of Glial Cell Activation through Dendritic Cell Vaccination: Promises for Treatment of Neurodegenerative Diseases.
Sabahi M; Joshaghanian A; Dolatshahi M; Jabbari P; Rahmani F; Rezaei N
J Mol Neurosci; 2021 Jul; 71(7):1410-1424. PubMed ID: 33713321
[TBL] [Abstract][Full Text] [Related]
12. Microglial phagocytosis is enhanced by monomeric alpha-synuclein, not aggregated alpha-synuclein: implications for Parkinson's disease.
Park JY; Paik SR; Jou I; Park SM
Glia; 2008 Aug; 56(11):1215-23. PubMed ID: 18449945
[TBL] [Abstract][Full Text] [Related]
13. Astrocytes are less efficient in the removal of apoptotic lymphocytes than microglia cells: implications for the role of glial cells in the inflamed central nervous system.
Magnus T; Chan A; Linker RA; Toyka KV; Gold R
J Neuropathol Exp Neurol; 2002 Sep; 61(9):760-6. PubMed ID: 12230322
[TBL] [Abstract][Full Text] [Related]
14. Nigrostriatal degeneration determines dynamics of glial inflammatory and phagocytic activity.
Ayerra L; Abellanas MA; Basurco L; Tamayo I; Conde E; Tavira A; Trigo A; Vidaurre C; Vilas A; San Martin-Uriz P; Luquin E; Clavero P; Mengual E; Hervás-Stubbs S; Aymerich MS
J Neuroinflammation; 2024 Apr; 21(1):92. PubMed ID: 38610019
[TBL] [Abstract][Full Text] [Related]
15. Microglial phagocytosis of neurons in neurodegeneration, and its regulation.
Butler CA; Popescu AS; Kitchener EJA; Allendorf DH; Puigdellívol M; Brown GC
J Neurochem; 2021 Aug; 158(3):621-639. PubMed ID: 33608912
[TBL] [Abstract][Full Text] [Related]
16. Parkinson's Disease-Associated LRRK2 Interferes with Astrocyte-Mediated Alpha-Synuclein Clearance.
Streubel-Gallasch L; Giusti V; Sandre M; Tessari I; Plotegher N; Giusto E; Masato A; Iovino L; Battisti I; Arrigoni G; Shimshek D; Greggio E; Tremblay ME; Bubacco L; Erlandsson A; Civiero L
Mol Neurobiol; 2021 Jul; 58(7):3119-3140. PubMed ID: 33629273
[TBL] [Abstract][Full Text] [Related]
17. What are activated and reactive glia and what is their role in neurodegeneration?
Bennett ML; Viaene AN
Neurobiol Dis; 2021 Jan; 148():105172. PubMed ID: 33171230
[TBL] [Abstract][Full Text] [Related]
18. Sleep Loss Promotes Astrocytic Phagocytosis and Microglial Activation in Mouse Cerebral Cortex.
Bellesi M; de Vivo L; Chini M; Gilli F; Tononi G; Cirelli C
J Neurosci; 2017 May; 37(21):5263-5273. PubMed ID: 28539349
[TBL] [Abstract][Full Text] [Related]
19. Glia as a turning point in the therapeutic strategy of Parkinson's disease.
L' Episcopo F; Tirolo C; Testa N; Caniglia S; Morale MC; Marchetti B
CNS Neurol Disord Drug Targets; 2010 Jul; 9(3):349-72. PubMed ID: 20438439
[TBL] [Abstract][Full Text] [Related]
20. Lysosomal Functions in Glia Associated with Neurodegeneration.
Kreher C; Favret J; Maulik M; Shin D
Biomolecules; 2021 Mar; 11(3):. PubMed ID: 33803137
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
